• 

  Lab-Grown Mini-Brains Could Help Find Treatments for Alzheimer’s and Other Diseases
• 

  Native American Communities’ Dementia Care Cost Driven Up by Hospitalization
• 

  Testing a Drug’s Disease-Modifying Potential For Frontotemporal Dementia
• 

  Why Is Everyone So Mad About Aduhelm?
• 

  Ritalin for Alzheimer’s? Clinical Trial Explores Common ADHD Drug’s Effects For Treating Apathy
• 

  Is Transcranial Magnetic Stimulation Ready for Alzheimer’s?
• 

  Renewed Interest for Galantamine, an 18-Year-Old Alzheimer’s Drug
• 

  Medicare Is Deciding Now Whether To Cover Aduhelm—And All the Similar Drugs to Follow
• 

  The Questions Doctors Are Getting About Aduhelm Right Now—And Their Answers
• 

  What Is Aduhelm and How Does It Fight Alzheimer’s?
• 

  Aducanumab Approved: U.S. FDA Gives Biogen Alzheimer’s Drug Approval
• 

  Dementia or ADHD? A BrainTalk With Sandra Kooij
• 

  Drugmakers Explore Quantum Computing to Unlock an Alzheimer’s Cure
• 

  Telling Apart Parkinson’s Dementia and Lewy Body Dementia: It’s Complicated
• 

  Tom Seaver, Like Robin Williams, Had Lewy Body Dementia—A Neurologist Explains the Disease

Previous234Next